Ticagrelor

CAT: 0931-MF-0003220-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0931-MF-0003220-01Size:10 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
274693-27-5
Target
Cytochromes P450|||P2Y Receptor
Related Pathways
Metabolism|||Neuroscience|||GPCR/G Protein
Purity
>99.99%
Bioactivity
Ticagrelor (AR-C 126532XX), produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique (EU) and Possia (EU) .
Smiles
CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1
Molecular Formula
C23H28F2N6O4S
Molecular Weight
522.57
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Alternative Products

CatalogName
021849Ticagrelor
RM-T030701-01Ticagrelor Impurity A (Ticagrelor Enantiomer)
RM-T030702-01Ticagrelor Impurity B (Ticagrelor Isomer 2)
MBS6032257-01Ticagrelor-d7
TRC-D232265-10MGTicagrelor Acetate
TRC-D290045-5MGDeshydroxyethoxy Ticagrelor

Popular Products